Capstone Investment Advisors’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-6,411
| Closed | -$494K | – | 1633 |
|
|
2025
Q4 | $509K | Sell |
6,411
-5,809
| -48% | -$458K | ﹤0.01% | 1143 |
|
|
2025
Q3 | $921K | Buy |
+12,220
| New | +$837K | ﹤0.01% | 1066 |
|
|
2025
Q2 | – | Sell |
-7,800
| Closed | -$511K | – | 1620 |
|
|
2025
Q1 | $528K | Sell |
7,800
-138,683
| -95% | -$8.3M | ﹤0.01% | 1063 |
|
|
2024
Q4 | $6.58M | Buy |
146,483
+52,604
| +56% | +$2.95M | 0.02% | 458 |
|
|
2024
Q3 | $5.9M | Sell |
93,879
-72,788
| -44% | -$4.25M | 0.02% | 421 |
|
|
2024
Q2 | $9.84M | Buy |
166,667
+152,761
| +1,099% | +$9.56M | 0.03% | 316 |
|
|
2024
Q1 | $1.11M | Sell |
13,906
-136,978
| -91% | -$10.5M | ﹤0.01% | 1088 |
|
|
2023
Q4 | $11.9M | Sell |
150,884
-20,296
| -12% | -$1.44M | 0.04% | 313 |
|
|
2023
Q3 | $12M | Sell |
171,180
-5,919
| -3% | -$419K | 0.05% | 244 |
|
|
2023
Q2 | $12.2M | Buy |
177,099
+157,670
| +812% | +$11.2M | 0.06% | 222 |
|
|
2023
Q1 | $1.44M | Sell |
19,429
-16,374
| -46% | -$1.37M | 0.01% | 678 |
|
|
2022
Q4 | $3.34M | Buy |
35,803
+34,282
| +2,254% | +$3.31M | 0.02% | 527 |
|
|
2022
Q3 | $145K | Sell |
1,521
-6,071
| -80% | -$601K | ﹤0.01% | 1526 |
|
|
2022
Q2 | $703K | Sell |
7,592
-53,932
| -88% | -$5.26M | ﹤0.01% | 1136 |
|
|
2022
Q1 | $6.23M | Buy |
61,524
+60,878
| +9,424% | +$6.4M | 0.02% | 629 |
|
|
2021
Q4 | $67K | Sell |
646
-189
| -23% | -$17.5K | ﹤0.01% | 1650 |
|
|
2021
Q3 | $71K | Sell |
835
-15,934
| -95% | -$1.33M | ﹤0.01% | 1819 |
|
|
2021
Q2 | $1.4M | Buy |
16,769
+1,658
| +11% | +$136K | ﹤0.01% | 1141 |
|
|
2021
Q1 | $1.14M | Buy |
+15,111
| New | +$1.1M | ﹤0.01% | 1079 |
|
|
2020
Q1 | – | Sell |
-22,553
| Closed | -$1.51M | – | 1185 |
|
|
2019
Q4 | $1.68M | Buy |
+22,553
| New | +$1.58M | 0.01% | 888 |
|
|
2019
Q3 | – | Sell |
-91,483
| Closed | -$5.42M | – | 1362 |
|
|
2019
Q2 | $4.99M | Buy |
91,483
+7,717
| +9% | +$416K | 0.04% | 460 |
|
|
2019
Q1 | $4.52M | Buy |
83,766
+76,662
| +1,079% | +$4.73M | 0.04% | 383 |
|
|
2018
Q4 | $465K | Buy |
+7,104
| New | +$530K | 0.01% | 832 |
|
|
2017
Q2 | – | Sell |
-10,393
| Closed | -$815K | – | 686 |
|
|
2017
Q1 | $815K | Buy |
10,393
+4,033
| +63% | +$322K | 0.02% | 476 |
|
|
2016
Q4 | $501K | Sell |
6,360
-93,305
| -94% | -$7.55M | 0.02% | 586 |
|
|
2016
Q3 | $8.87M | Buy |
99,665
+32,624
| +49% | +$3.08M | 0.19% | 89 |
|
|
2016
Q2 | $6.42M | Buy |
+67,041
| New | +$6.68M | 0.12% | 120 |
|
|
2015
Q4 | – | Sell |
-8,000
| Closed | -$771K | – | 477 |
|
|
2015
Q3 | $771K | Buy |
+8,000
| New | +$841K | 0.02% | 244 |
|
|
2014
Q3 | – | Sell |
-3,500
| Closed | -$263K | – | 447 |
|
|
2014
Q2 | $263K | Buy |
+3,500
| New | +$265K | ﹤0.01% | 372 |
|
Other funds holding CVS
VCM
VPM
Capstone Investment Advisors's CVS Position: Q1 2026 in Review
Capstone Investment Advisors sold out of CVS Health (CVS) in Q1 2026, closing a stake of 6,411 shares — an estimated $494K sold.
Capstone Investment Advisors first reported a position in CVS in Q2 2014 and held it in 29 quarters. The position peaked at $12.2M in Q2 2023. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Capstone Investment Advisors reported no remaining CVS Health position as of Q1 2026 after selling out during the quarter.
- Capstone Investment Advisors sold 6,411 CVS Health shares in Q1 2026, an estimated $494K.
- Capstone Investment Advisors first reported a position in CVS Health in Q2 2014 and held it in 29 quarters.
- Capstone Investment Advisors's CVS Health position peaked at $12.2M in Q2 2023.
- 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Capstone Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.